Article
Health Plans,
Article,
Hypertension,
Employers
How consistent blood pressure data becomes a catalyst to better care
Navigating the New Age of Type 2 Diabetes and Obesity Management
The mounting popularity of GLP-1 therapies is changing how people—and the healthcare system—address type 2 diabetes and obesity care. We'll explore the opportunities and risks of these therapies and examine the role of these medications in the long-term management of two of the costliest conditions organizations face.
Fill out this form to get access.
Meet your speakers
Related Insights
Article
Chronic Care,
Health Plans,
Diabetes,
Article,
Hypertension,
The Catalyst,
Obesity & Weight Care,
Employers
With AI doing heavy lifting, humans can help people achieve better health
Article
Chronic Care,
Health Plans,
Diabetes,
Article,
Mental Health,
Hypertension,
Primary Care,
The Catalyst,
Obesity & Weight Care,
Employers
The next competitive advantage for health plans isn’t another point solution
Video
Health Plans,
2026,
Video,
The Catalyst,
Virtual Care Platform,
Employers
Erasing the line between AI, virtual and in-person care
Video
Chronic Care,
Health Plans,
Forum,
2026,
Video,
The Catalyst,
Virtual Care Platform,
Employers
How a six-year partnership delivers on consumer health needs
Article
Health Plans,
Article,
The Catalyst,
Virtual Care Platform,
Obesity & Weight Care,
Employers
GLP-1 program infrastructure: the medication is no longer the hard part
Case Study
Chronic Care,
Diabetes,
Hypertension,
Primary Care,
Case Study,
Obesity & Weight Care,
Employers
Gallagher and Teladoc Health partner to expand care access for a local government workforce
Article
Health Plans,
Article,
Virtual Care Platform,
Employers
Five Strategic Shifts Defining the Future of AI in Healthcare
Article
Chronic Care,
Health Plans,
Diabetes,
Article,
The Catalyst,
Virtual Care Platform,
Employers
A virtual medical home: What happens when care finally connects